Follow glycogen from branching and synthesis to tissue-specific fuel use, then apply regulation, energy accounting and compartment logic to original cases.
A runner can use muscle glycogen while the liver supplies glucose to the rest of the body. Those are different jobs performed with the same stored polymer. Follow one glucose unit, its phosphate and its compartment. The names become easier when you can predict what the next reaction must accomplish.
A compact reserve with many usable ends
Imagine two equal stores of glucose. One is a long unbranched strand. The other has many short arms. Predict which presents more places for enzymes to work at once. Glycogen uses alpha-1,4 linkages along each arm and alpha-1,6 linkages at branch points. Its many nonreducing ends are accessible working surfaces. The reducing end is conventionally associated with a glycogenin protein core.
Branching helps create a compact, soluble reserve with many termini. It does not mean every bond can be cut by the same enzyme. Alpha describes the configuration at the glucose anomeric carbon; 1,4 and 1,6 identify the connected carbon positions. A branch joins carbon 1 of one residue to carbon 6 of another. Branching reactionPrimer reaction
Count the usable ends
Keep glucose mass equal. Select an architecture and count its terminal tips.
Unbranched. Fourteen residues provide one nonreducing terminal tip. Folding the drawing does not create a chemical branch.
Does bending the strand add an alpha-1,6 linkage? No. A chemical branch requires a new alpha-1,6 junction.
Branched. The same fourteen residues provide three nonreducing terminal tips. Branching changes access without adding stored glucose.
Which quantity stayed fixed? The total number of glucose residues stayed fixed.
Original Bone Wizardry schematic, 2026. Qualitative teaching model. [3][1]
Try a structural prediction. Compare equal numbers of glucose circles in the two structures. Count their terminal tips before reading the result. More accessible ends can support greater initial access when enzyme and substrate conditions permit. That is a mechanistic prediction, not a universal proportional rate law. Enzyme amount, allostery and the remaining substrate also constrain flux.
Storing glucose as a polymer limits the osmotic burden compared with the same number of separate glucose molecules. Liver glycogen supports the blood-glucose supply between meals. Muscle glycogen is a local reserve for contraction. Muscle contains a large total body pool, but possession of stored carbon does not establish an ability to export it directly as glucose.
Predict the effect of fewer branches at equal glucose mass
There are fewer nonreducing ends. That can reduce simultaneous enzyme access. It does not change phosphorylase into an enzyme that hydrolyzes branch points.
Pay for an activated donor before adding glucose
A meal supplies glucose, but glycogen synthase cannot simply attach free glucose to glycogen. First the cell traps and prepares it. Hexokinase in muscle and glucokinase in liver use ATP to make glucose-6-phosphate, abbreviated G6P. Glucokinase operates over a higher glucose range than typical hexokinases; it is not an enzyme that can never saturate. Glucokinase propertiesHexokinase reaction
Phosphoglucomutase rearranges G6P to glucose-1-phosphate, or G1P, through a glucose-1,6-bisphosphate intermediate. The enzyme can work in the reverse direction during breakdown. UDP-glucose pyrophosphorylase then combines G1P with UTP. The products are UDP-glucose and pyrophosphate. Pyrophosphate hydrolysis helps favor donor formation. The resulting UDP-glucose is the donor used for elongation. PhosphoglucomutaseUDP-glucose formation
Bypass a donor-activation defect
Interrupt donor formation, then supply the product of that reaction. Compare the visible route.
Normal route. G1P and UTP supply UDP-glucose. Synthase uses this donor with an existing primer.
Does synthase consume free glucose directly? No. Its glucosyl donor is UDP-glucose.
Interrupt activation. The crossed activation step prevents production of sufficient UDP-glucose. Upstream G1P cannot directly serve synthase.
Would more G1P bypass this interruption? No. G1P still needs the interrupted donor-activation reaction.
Supply UDP-glucose. Added donor enters after the interrupted step. With primer and synthase intact, incorporation resumes in this hypothetical assay.
What can the rescue establish? It localizes a requirement upstream of supplied UDP-glucose under the assay conditions.
Original Bone Wizardry schematic, 2026. Qualitative teaching model. [6][2][25]
Choose a rescue substrate. In the original hypothetical preparation above, adding UDP-glucose restores incorporation after donor activation is interrupted. Adding more G1P does not bypass that interruption. Read the route from the supplied substrate onward. This is a way to localize a reaction in a controlled assay; it is not sufficient to establish a patient’s entire diagnosis.
Glycogenin conventionally initiates a short glucose primer on a tyrosine residue. Glycogen synthase extends a pre-existing glucan by adding alpha-1,4-linked residues at nonreducing ends. The branching enzyme transfers an existing segment to create an alpha-1,6 connection. Synthase does not make the branch itself. Descriptions such as transferring roughly seven residues illustrate typical architecture; branch sizes and spacing are not fixed counts in every glycogen particle. SynthaseBranching enzyme
A primer-rescue experiment asks a different question from a donor-rescue experiment. If UDP-glucose is already available but a short added glucan restores synthesis, the supplied material replaces an acceptor. If incorporation from UDP-glucose remains poor despite a primer, elongation is implicated. Changing one requirement at a time lets the observation support a bounded conclusion. An already glucosylated protein can supply an acceptor even if its own priming catalysis is disabled. That is different from an inactive protein with no attached glucan. A normal isolated enzyme also requires a control for inhibitors that may have been lost during purification. Primer chemistry
What would extra branching enzyme fail to replace?
It would not replace UDP-glucose formation or the initial glucan acceptor. Branching rearranges an existing segment after there is suitable glucan substrate.
Release most residues with phosphate, then clear a branch
Breakdown is not synthesis run backward with the same enzymes. Glycogen phosphorylase uses inorganic phosphate to cleave terminal alpha-1,4 linkages. This phosphorolysis releases G1P. Water is not the reagent supplying the phosphate, and ATP is not consumed in each cleavage. Phosphorylase approaches a branch but stops when four residues remain on that outer arm. Phosphorylase reaction
Clear the branch one operation at a time
Predict the product before selecting each operation. Return to any state without a required sequence.
Four-residue limit. Phosphorylase cannot clear this branch-adjacent stub. Four residues remain on its outer arm.
Which linkage will ultimately require water? The alpha-1,6 branch linkage requires hydrolysis.
Transfer three. Transferase relocates three terminal residues onto another arm. One glucose remains at the alpha-1,6 junction.
What substrate is now exposed? A single branch-point glucose is exposed for glucosidase.
Hydrolyze one. Alpha-1,6-glucosidase uses water to release the exposed branch glucose. This product is free glucose.
Is this released product G1P? No. Hydrolysis releases unphosphorylated glucose.
Resume with Pi. Phosphorylase resumes on accessible alpha-1,4 residues. The diagram shows glucose-1-phosphate released from two accessible bonds.
What supplies phosphate to these products? Inorganic phosphate supplies it during phosphorolysis.
Original Bone Wizardry schematic, 2026. Qualitative teaching model. [1][4][5]
Predict each operation before selecting it. The transferase activity of the mammalian debranching enzyme transfers three residues to another glucan arm. One alpha-1,6-linked glucose remains at the branch. The enzyme’s separate alpha-1,6-glucosidase activity hydrolyzes that linkage with water, releasing free glucose. Phosphorylase can then continue along the newly accessible alpha-1,4 segment. Both debranching activities reside on the AGL-encoded protein, but they perform distinct reactions. TransferaseBranch hydrolysis
Most released residues therefore enter metabolism as G1P, while branch-point residues enter as free glucose. The exact fraction depends on architecture. G1P becomes G6P through phosphoglucomutase. A free branch glucose must be phosphorylated if it is to enter local glycolysis. That distinction matters when accounting for energy.
Phosphoglucose isomerase converts G6P to fructose-6-phosphate. PFK then uses ATP to form fructose-1,6-bisphosphate. These shared reactions are downstream of the point where free glucose and glycogen-derived carbon reach G6P. Phosphoglucose isomerase changes the sugar structure; phosphoglucomutase instead rearranges the phosphate position between G1P and G6P. Isomerase reactionPFK reaction
One six-carbon glucose equivalent is split into two three-carbon intermediates. Each passes through two ATP-forming reactions, phosphoglycerate kinase and pyruvate kinase. Together they form four ATP. Conversion of pyruvate to lactate regenerates NAD+ from NADH so glycolysis can continue; that conversion does not make additional ATP. Lactate dehydrogenase reaction Blood glucose costs one ATP at hexokinase and another at phosphofructokinase, leaving two net ATP. A phosphorylase-released glycogen residue bypasses the hexokinase expense. It still pays the PFK expense, leaving three net ATP. These counts exclude earlier glycogen synthesis, resynthesis and oxidative phosphorylation. PFK investmentFirst ATP payoffSecond ATP payoff
Work a mixed example. Eight G1P-released residues and two free branch glucoses yield 8 times 3 plus 2 times 2, or 28 net ATP, when all ten complete glycolysis to lactate under those assumptions. The example is invented bookkeeping, not a measured clinical energy yield. A flat lactate response in muscle can reflect several different pathway defects.
Why does a normal exposed-branch glucosidase assay not prove normal debranching?
It tests hydrolysis after the branch glucose is already exposed. A transferase defect can still prevent exposure of that substrate within the intact four-residue stub.
The phosphate decides whether glucose can leave
G6P is charged and does not simply exit through the usual glucose transport route. In glucose-exporting tissues, G6P enters the endoplasmic reticulum glucose-release system. Transport and catalytic hydrolysis are separate requirements. Glucose-6-phosphatase releases free glucose and phosphate. Liver can then support blood glucose. Renal cortex also produces glucose, with gluconeogenic precursors such as lactate supplying newly synthesized G6P. This renal route is not a hepatic-type glycogen reserve. Human isotope and renal-balance work supports precursor-derived renal glucose production; its contribution varies with physiologic context. Primary human renal studyHuman cortical-slice experiments “Only liver can release glucose” is too absolute. G6P hydrolysisThe hepatic and renal system
Compare routes through G6P
Compare glycogen-derived G6P in liver and muscle with newly synthesized G6P in renal cortex.
Liver. Hepatic G6P reaches the ER system and is hydrolyzed before free glucose enters blood.
What extra reaction separates mobilization from export? G6P hydrolysis supplies free glucose.
Skeletal muscle. Muscle G6P enters local glycolysis. A stronger mobilizing signal does not create the missing direct G6Pase export system.
How can muscle carbon support blood glucose indirectly? Muscle lactate can provide carbon for hepatic gluconeogenesis.
Renal cortex. Gluconeogenic precursors supply newly synthesized G6P in renal cortex. ER G6P hydrolysis permits free-glucose export. Contribution varies with physiologic context.
Which carbon source starts this renal route? Lactate and other gluconeogenic precursors supply the depicted renal route.
Original Bone Wizardry schematic, 2026. Qualitative teaching model. [26][12][23][41][43]
Compare the routes at G6P. The liver and muscle states begin with glycogen; the renal cortical state begins with gluconeogenic precursors. In skeletal muscle, G6P enters local glycolysis because the physiologically important G6Pase glucose-export system is absent. Glucagon cannot supply a missing enzymatic pathway. Muscle uses its glycogen for its own energetic demand. Its released lactate can travel to liver, where gluconeogenesis converts carbon back toward glucose. That Cori-cycle contribution is indirect and requires energy elsewhere. Muscle can also transfer gluconeogenic carbon as alanine derived from pyruvate. A labeled-carbon experiment must measure the delivered precursors before selecting the lactate route over this alternative. Human muscle and splanchnic exchange study
In a hypothetical microsomal experiment, hydrolysis that recovers after membrane disruption suggests a substrate-access limitation. If the catalytic enzyme itself is severely deficient, exposing the compartment does not restore its missing chemistry. The assay separates transport from catalysis under its tested conditions; clinical subtype assignment still requires appropriate molecular and clinical evidence.
As fasting continues, hepatic glycogen contribution generally falls and gluconeogenesis contributes more. Gluconeogenesis is already active during an overnight fast. Human tracer and magnetic-resonance work supports overlapping contributions, not an exact universal switch at 12 or 24 hours. Meal history, activity, age and illness alter reserve use. An active phosphorylase enzyme cannot sustain a high rate after its usable substrate becomes scarce. Human fasting experiment
Why can labeled muscle carbon later appear as hepatic glucose?
Muscle can release labeled lactate. Liver can use that carbon for gluconeogenesis. The observation does not establish direct release of free glucose from muscle glycogen.
Combine the hormonal message with local demand
A meal and a muscle contraction ask different questions of glycogen. Insulin favors storage through several coordinated effects, including glycogen-synthase dephosphorylation and inhibition of glycogen-synthase kinase 3 through Akt signaling. Phosphatases can reverse phosphate modifications already present on proteins. A rapid change does not require synthesis of an entirely new enzyme population. Experimental insulin signaling
Compare systemic and local signals
Select the physiological condition and inspect which enzyme target receives the signal.
After a meal. Insulin favors synthase activation through coordinated signaling and dephosphorylation. G6P also provides an allosteric input.
Must enzyme abundance change first? No. Existing proteins can change activity rapidly.
Does phosphorylation affect both targets in the same direction? No. The functional consequence depends on the protein target.
Muscle contraction. Calcium acts through the calmodulin subunit of phosphorylase kinase. Local contraction signaling can complement adrenergic inputs.
Does this input require a muscle glucagon response? No. Calcium supplies a local regulatory input.
Original Bone Wizardry schematic, 2026. Qualitative teaching model. [8][10][9][27][15]
Compare the three conditions. During hepatic fasting signaling, glucagon can increase cAMP, activate protein kinase A and promote phosphorylase-kinase activation. Phosphorylase kinase activates phosphorylase by phosphorylation. PKA-associated phosphorylation also favors reduced glycogen-synthase activity. The same type of chemical modification can have opposite effects on different protein targets. “Phosphorylation turns everything on” fails here. Professional pathway summary
Epinephrine supports glycogen mobilization through tissue-appropriate adrenergic signaling. During muscle contraction, calcium binds the calmodulin delta subunit of phosphorylase kinase. This couples calcium availability to fuel mobilization as well as to contraction. Calcium and phosphorylation are interacting inputs, not a demand that a glucagon signal first arrive at skeletal muscle. A beta-adrenergic blockade experiment may alter one input without eliminating every calcium-dependent response. Phosphorylase kinase structure
Allostery adds local information. AMP can favor activation of muscle phosphorylase b; ATP and G6P oppose that low-energy signal. Liver and muscle isoforms do not have identical regulation. G6P also allosterically stimulates glycogen synthase. In experimental muscle, impaired G6P responsiveness can reduce insulin-stimulated synthesis even when phosphorylation-related signaling is preserved. Those experimental results support a mechanism and do not establish a patient treatment. Phosphorylase allosterySynthase allostery
For phosphorylase, the a form is phosphorylated and the b form is dephosphorylated. These names describe a covalent state, not an absolute on/off switch. Removing free regulatory nucleotides from an assay does not itself remove phosphate covalently attached to a protein. Compare ligand withdrawal with phosphatase treatment before deciding which response should persist. Local ligands can still alter activity. In liver, abundant free glucose can inhibit phosphorylase a and favor its dephosphorylation. That feedback connects available glucose to reduced hepatic reserve use. In a controlled assay, immediate inhibition while phosphate state is fixed supports allostery; a later decline in enzyme phosphorylation supports a second regulatory process. Hepatic feedback experiment
Finally, stored amount and flux are different measurements. An unchanged glycogen mass could mean no turnover, or equal rates of synthesis and degradation. If a hypothetical pool contains 100 units and gains ten while losing ten, its net size is unchanged despite active turnover. Tracers can resolve that ambiguity when a single mass measurement cannot.
What does cAMP rescue after receptor stimulation fails localize?
It supports a limitation upstream of cAMP action, such as receptor coupling or adenylyl cyclase. It does not, by itself, identify which upstream component is defective.
Use a pathway failure to predict the consequence
Begin with the missing job. GSD I interrupts the final G6P-dependent glucose-release system. Both glycogenolysis and gluconeogenesis encounter that shared exit problem. Severe fasting hypoglycemia can coexist with abundant hepatic glycogen, lactate elevation, hyperuricemia and hyperlipidemia. GSD Ia affects catalytic G6Pase; Ib affects the transporter and can include neutropenia and infections. Detectable ketones do not create an absolute exclusion rule. Clinical fuel context Hepatic adenomas and renal complications require continued assessment. GSD I
GSD III impairs debranching, leaving limit-dextrin material. Gluconeogenesis remains available, so fasting ketosis and specialist-directed protein support fit a different physiology from GSD I. IIIa can involve skeletal and cardiac muscle; IIIb is liver restricted. GSD IV impairs branching and can produce long, poorly branched polyglucosan material. Hepatic and neuromuscular courses vary. Progressive cirrhosis is an important presentation, not an inevitable outcome in every affected person. GSD IIIGSD IV
GSD VI affects hepatic phosphorylase. GSD IX affects phosphorylase kinase, with gene- and tissue-dependent patterns. Both can cause ketotic hepatic disease and require individualized follow-up even when symptoms become milder. GSD V affects muscle phosphorylase, making early exercise difficult; circulating fuel can support second wind. GSD VII affects muscle-type PFK, so blood glucose still encounters the downstream glycolytic block; hemolysis can accompany myopathy. GSD 0 can reflect deficient glycogen synthesis and too little reserve. GSD VPFKM studyGSD 0
Pompe disease, GSD II, is different again. Lysosomal GAA deficiency causes compartmental glycogen accumulation despite potentially functioning cytosolic phosphorolysis. Infantile disease commonly involves cardiomyopathy and hypotonia; later-onset disease often emphasizes proximal and respiratory weakness. Current replacement enzymes target GAA with product-specific indications and immune considerations. These are specialist therapies, not interchangeable substitutes for all glycogen disorders. Pompe diseaseAlglucosidase labelAvalglucosidase labelCipaglucosidase label
Transfer the mechanism. Ask whether blood glucose enters before or after the defect, whether gluconeogenesis has a usable exit, and whether the stored material is cytosolic or lysosomal. Those three predictions explain why cornstarch plans, exercise strategies and enzyme replacement are disease specific. Diagnostic glucagon challenges are not recommended for GSD I; they can worsen metabolic acidosis. Exercise testing and carbohydrate strategies also require appropriate supervision and interpretation. GSD I guidanceSmall exercise-substrate study
For the full clinical comparison, continue within the site to Glycogen storage diseases. You can study either document independently. No chapter completion or account is required to read these lessons.
These original hypothetical cases ask you to use evidence, predict a consequence or interpret an experiment. Choose an option, then inspect its reasoning one question at a time. Every option also has a complete explanation. Assay values and scenarios are teaching constructions unless a cited study is explicitly discussed.
Case 1
Show answer and explanations for case 1
A. P labeled glucose is maintained; Q labeled lactate decreases (Best answer)
Hepatic G6P hydrolysis provides free glucose. The muscle lactate label depends on glycolytic PFK flux. Muscle labeled lactate falls despite preserved hepatic glucose-release capacity. Follow each measured product beyond the shared G6P intermediate.
B. P labeled glucose decreases; Q labeled lactate decreases (Why this does not fit)
An interruption before the two routes separate could reduce both outputs. The experiment holds glycogen-derived G6P supply constant. Blocking glycolysis is different from blocking formation of G6P.
C. P labeled glucose decreases; Q labeled lactate is maintained (Why this does not fit)
Loss of G6P hydrolysis would impair the hepatic export route. The inhibited reaction is PFK within the muscle lactate route. A terminal glucose-export defect would reverse the predicted tissue pattern.
D. P labeled glucose is maintained; Q labeled lactate is maintained (Why this does not fit)
Glycogen-derived carbon is traversing local glycolysis. Its passage through PFK is interrupted. Adequate oxygen does not bypass a blocked glycolytic reaction.
Takeaway: A shared intermediate does not make every downstream reaction shared.
A. Purified glycogen synthase (Why this does not fit)
The preparation can elongate the supplied glycogen primer. Synthase consumes UDP-glucose rather than producing it. Normal UDP-glucose incorporation already demonstrates functioning synthase in this assay.
B. Purified glycogen phosphorylase (Why this does not fit)
Phosphorylase liberates G1P from glycogen. G1P is already supplied but is poorly incorporated. Breakdown capacity does not replace the UDP-glucose-forming reaction.
C. Purified UDP-glucose pyrophosphorylase (Best answer)
Glucose-1-phosphate must be converted to UDP-glucose. UDP-glucose pyrophosphorylase produces the activated donor. Restore donor activation before expecting elongation from G1P.
D. Purified glucose-6-phosphatase (Why this does not fit)
It produces free glucose from G6P. Free glucose still requires activation before glycogen synthase can use it. Dephosphorylation for export does not activate a glucose donor.
Takeaway: A rescue substrate must enter after the defective reaction.
A. Catalytically inactive glycogenin carrying an accessible preformed short glucan (Best answer)
The preparation can make UDP-glucose. The isolated synthase can catalyze elongation. Its preformed glucan supplies an elongatable acceptor. Supplying an existing glucan tests acceptor availability.
B. Additional active branching enzyme without an associated glucan (Why this does not fit)
It could correct deficient branch-forming activity. Branching activity is already normal. Restoring branch formation would address a different synthetic limitation.
C. Additional active glycogen synthase without an associated glucan (Why this does not fit)
The isolated enzyme extends the standard supplied glucan normally. An initial glucan acceptor is still missing. An elongation enzyme still needs an acceptor.
D. Additional UDP-glucose without an associated glucan (Why this does not fit)
UDP-glucose production is normal. It needs a pre-existing glucan to extend. More donor does not replace an acceptor limitation.
Takeaway: A preformed primer can supply an acceptor even when its own priming catalysis is inactive.
A. Equal glucose-residue concentration, with a phosphate titration and the same enzyme batch (Why this does not fit)
It would test whether phosphate availability limits phosphorolysis. The original comparison supplies excess phosphate. A phosphate titration tests reagent limitation rather than unequal terminal access.
B. Equal glucose-residue concentration, with debranching enzyme and the same enzyme batch (Why this does not fit)
It can clear branch-adjacent limits to continued degradation. The initial rates were measured before branch limits. Branch clearance matters after the branch limit is reached.
C. Equal accessible-terminal concentration, with excess phosphate and the same enzyme batch (Best answer)
A supplies more accessible nonreducing termini. Matching accessible-terminal concentration removes the terminal-number advantage. Residual differences would implicate properties beyond terminal count. Equalizing accessible ends directly tests the terminal-number explanation.
D. Equal alpha-1,6-junction concentration, with excess phosphate and the same enzyme batch (Why this does not fit)
It would standardize the number of branch junctions. Accessible nonreducing alpha-1,4 termini support that cleavage. Junction count is not the concentration of accessible phosphorylase substrates.
Takeaway: Normalize the substrate feature under test; do not turn branching into a universal rate law.
A. Two from glycogen and three from blood glucose (Why this does not fit)
The blood-glucose route pays that ATP. An extra investment lowers net ATP yield. The ATP saving belongs to the phosphorylated glycogen entry route.
B. Two from glycogen and two from blood glucose (Why this does not fit)
Inorganic phosphate is incorporated during phosphorolysis. Blood glucose requires ATP at hexokinase. Equal lactate output does not imply equal investment costs.
C. Four from glycogen and two from blood glucose (Why this does not fit)
The payoff reactions form four ATP per glucose equivalent. Phosphofructokinase still consumes one ATP. Bypassing hexokinase does not bypass phosphofructokinase.
D. Three from glycogen and two from blood glucose (Best answer)
It bypasses the hexokinase ATP cost. Four ATP produced minus one ATP invested gives three net ATP. The additional hexokinase investment leaves two net ATP. This comparison applies to a phosphorylase-released residue, not every branch glucose.
Takeaway: Phosphorolysis saves the ATP otherwise spent by hexokinase.
A. T appears in G1P; J appears in free glucose (Why this does not fit)
It would appear after alpha-1,6 hydrolysis. Junction hydrolysis is selectively inhibited. Restoring transfer does not cancel a separate glucosidase inhibitor.
B. T remains glucan-bound; J remains glucan-bound (Why this does not fit)
Persistent transfer failure could retain tracer T there. Transfer is restored with a suitable acceptor available. The replacement restores the operation needed to expose and relocate the outer residues.
C. T appears in free glucose; J remains glucan-bound (Why this does not fit)
Hydrolytic alpha-1,4 cleavage could produce free glucose. Phosphorylase releases them as G1P. The active outer-residue release route is phosphorolytic.
D. T appears in G1P; J remains glucan-bound (Best answer)
It excludes loss of the tested junction-hydrolysis capacity in the original extract. They place T on the supplied accessible glucan acceptor. Tracer T appears in G1P. Tracer J remains attached through its alpha-1,6 linkage. Transfer and junction hydrolysis determine different tracer fates.
Takeaway: Transferred residues can be mobilized while the uncleared junction remains attached.
A. G1P from phosphate-dependent phosphorolysis (Why this does not fit)
Phosphorylase cleaves accessible alpha-1,4 residues with inorganic phosphate. The labeled junction residue is released without inorganic phosphate. Phosphorolysis requires the phosphate omitted from this assay.
B. Free glucose from water-dependent hydrolysis (Best answer)
It cuts the remaining alpha-1,6 linkage. Hydrolysis releases unphosphorylated glucose. The branch product has not yet undergone hexokinase phosphorylation.
C. G6P from hydrolysis followed by hexokinase phosphorylation (Why this does not fit)
Hexokinase could phosphorylate it after release. The product is sampled before downstream enzymes are added. A later cellular product is different from the immediate sampled product.
D. Glucan-bound glucose after transfer without soluble-product release (Why this does not fit)
It would leave glucose incorporated within glucan. The branch-clearing fraction releases the labeled residue. Transfer alone redistributes glucosyl residues without releasing the measured soluble residue.
Takeaway: Branch hydrolysis releases free glucose before any later phosphorylation.
A. F6P phosphorylation by phosphofructokinase (Why this does not fit)
G6P reaches lactate through the PFK reaction. The downstream glycolytic route is functioning. The downstream rescue requires functional phosphofructokinase.
B. Glycogen cleavage by muscle phosphorylase (Why this does not fit)
G1P release from glycogen is normal. More phosphorylase would supply the same poorly utilized intermediate. Normal G1P release places the block after phosphorylase.
C. G1P conversion to G6P by phosphoglucomutase (Best answer)
Normal phosphorylase activity supplies G1P. Supplied G6P supports lactate production. Phosphoglucomutase interconverts G1P and G6P. G1P can accumulate despite intact phosphorylase.
D. G6P hydrolysis by glucose-6-phosphatase (Why this does not fit)
G6P can enter local glycolysis directly. Skeletal muscle normally lacks the glucose-6-phosphatase export system. Muscle glycolysis consumes G6P without hydrolyzing it first.
Takeaway: Measure the reaction between the accumulating substrate and the rescuing product.
A. Increasing glycogen phosphorylase phosphorylation (Why this does not fit)
The cells generated more G6P after glucagon. The intact microsomal membrane prevents effective access to catalytic hydrolysis. Producing more G6P does not transport it into the ER.
B. Increasing lysosomal acid alpha-glucosidase activity (Why this does not fit)
Disrupting microsomes restored G6P hydrolysis. A lysosomal enzyme does not supply the ER G6P transporter. The failing free-glucose pathway was localized to microsomes.
C. Restoring ER G6P transport (Best answer)
The catalytic G6Pase activity is available. Disruption bypasses ER substrate transport. Restoring G6P transport would restore substrate access in the model. Transport and catalysis are separate requirements of the G6Pase system.
D. Increasing hepatic glucagon receptor density (Why this does not fit)
cAMP increased after glucagon. Rescue occurs at the microsomal G6P-handling step. The measured cAMP and G6P responses already establish upstream signaling.
Takeaway: A normal enzyme can be inaccessible to its substrate.
A. Active PKA catalytic subunit (Why this does not fit)
PKA can phosphorylate phosphorylase-kinase regulatory targets. Free calcium remains undetectable. Calcium is an interacting requirement of phosphorylase kinase activation.
B. Additional inorganic phosphate (Why this does not fit)
It could help if phosphate substrate were limiting. Buffering calcium prevents the rise in phosphorylase phosphorylation at matched phosphate. More cleavage substrate does not specifically repair an activation defect.
C. Catalytically active phosphorylase a (Best answer)
The calcium-triggered phosphorylation response remains available. The glycogen-cleaving target is usable once activated. Phosphorylase a supplies the activated glycogen-cleaving enzyme. Supply the active downstream target when its calcium-dependent activation fails.
D. Additional calcium-free calmodulin (Why this does not fit)
Calcium binding mediates the local signal. The calcium buffer still prevents the required ligand rise. Adding the calcium sensor does not supply its missing signal.
Takeaway: A downstream active enzyme can bypass a missing regulatory input in a controlled assay.
A. Loss of PKA catalytic activity or loss of phosphorylase-kinase catalytic activity (Why this does not fit)
Both measured kinase responses returned to control values. Complete loss would prevent the corresponding recovered kinase reaction. Downstream rescue requires the kinase activities proposed as absent.
B. Failure of receptor coupling or loss of phosphorylase catalytic activity (Why this does not fit)
Supplied cAMP bypasses receptor coupling. G1P production returns to control values. The receptor alternative fits, but the paired catalytic-loss alternative does not.
C. Failure of receptor coupling or loss of adenylyl-cyclase catalytic activity (Best answer)
The downstream cAMP-responsive pathway can function. Receptor coupling or cyclase catalysis can each fail before cAMP is available. Neither a receptor-binding nor a direct cyclase assay has been performed. The experiment has not separated coupling from cAMP synthesis.
D. Accelerated cAMP degradation or loss of PKA responsiveness to cAMP (Why this does not fit)
cAMP degradation matches controls. Supplied cAMP restores PKA activity. The degradation control and the PKA rescue address these two alternatives separately.
Takeaway: A successful bypass can exclude downstream failures while leaving several upstream causes open.
A. Increase UDP-glucose, then compare activity without changing phosphorylation (Why this does not fit)
It could compensate for inadequate donor availability. Donor availability matches the control preparation. A donor challenge tests substrate limitation rather than the stated competing regulatory mechanisms.
B. Treat isolated synthase with phosphatase, verify phosphate loss, then assay at matched low G6P (Best answer)
Existing synthase phosphate is not thereby removed. Phosphatase treatment can remove the retained regulatory phosphate. Recovery then tests whether retained phosphorylation accounts for the activity deficit. An activity rescue after verified dephosphorylation supports a regulatory rather than intrinsic catalytic limitation.
C. Further inhibit GSK3, then assay before measuring phosphate removal (Why this does not fit)
Insulin inhibits GSK3 normally. Whether phosphate already on synthase has been removed would remain unknown. Reduced kinase pressure is not a verified dephosphorylation experiment.
D. Increase the supplied primer, then compare activity without changing phosphorylation (Why this does not fit)
It would address inadequate glucan acceptor supply. Primer availability already matches the control preparation. An acceptor challenge does not isolate the effect of retained regulatory phosphate.
Takeaway: Verify the modification change before interpreting the activity rescue.
A. A smaller activity increase from the matched intermediate state to complete dephosphorylation without G6P (Why this does not fit)
Without G6P, the variant and control have identical donor and primer activity curves at the matched intermediate phosphorylation pattern and after complete dephosphorylation. At the same donor and primer concentrations, equal starting and ending activities give equal increases after complete phosphate removal. These defined endpoint comparisons exclude a smaller G6P-free dephosphorylation response; they do not establish all responses to partial phosphate removal or to G6P.
B. A lower maximal activity after full dephosphorylation at saturating donor (Why this does not fit)
It would imply impaired maximal synthase catalytic capacity. Maximal activity after dephosphorylation is normal. A reduced maximal catalytic capacity conflicts with the direct capacity control.
C. A higher donor requirement in the absence of G6P (Why this does not fit)
It could reduce synthesis at a given UDP-glucose concentration. Donor kinetics without G6P match controls. Altered donor kinetics are a different explanation from a missing regulatory input.
D. A smaller activity increase with G6P at the matched intermediate phosphorylation state (Best answer)
The supplied assays preserve substrate handling and the defined G6P-free dephosphorylation response, but do not test activation by G6P. Reduced G6P responsiveness would predict a smaller activity rise when G6P is added at the same intermediate phosphorylation pattern. Matching regulatory-site occupancy and verifying it remains unchanged prevents altered phosphate removal from accounting for that assay difference. Phosphorylation and G6P regulation interact, so the inference is limited to this controlled G6P comparison rather than a unique molecular lesion.
Takeaway: Matched phosphorylation and G6P-free controls do not establish the response to a new G6P challenge.
A. A retains activation; B returns toward its initial activity (Why this does not fit)
A loses unbound AMP during exchange. B retains its increased enzyme phosphate content. This pattern reverses the persistence of noncovalent and covalent inputs.
B. B retains activation; A returns toward its initial activity (Best answer)
Nucleotide-dependent allostery explains A. Its covalently attached regulatory phosphate remains. B retains the activation associated with its phosphorylated state. Covalent activation can persist after free allosteric ligands are withdrawn.
C. Both retain activation (Why this does not fit)
A was activated without a phosphate-content change. It removes the elevated free AMP. Prior ligand exposure does not establish persistent covalent activation.
D. Both return toward their initial activity (Why this does not fit)
A phosphatase could remove its regulatory phosphate. The measured enzyme phosphate content remains unchanged. Removing free nucleotides does not hydrolyze covalently attached protein phosphate.
Takeaway: Ligand withdrawal and protein dephosphorylation reverse different regulatory inputs.
A. Add a standardized glycogen substrate to the late extract and measure G1P at unchanged phosphorylation (Best answer)
The available hepatic glycogen reserve falls. It reduces alternative explanations based on the assay environment. Glycogen repletion would raise late-sample G1P flux without further enzyme activation. A substrate-repletion challenge tests the proposed stock limitation.
B. Add phosphorylase kinase to the late extract and measure G1P at unchanged glycogen (Why this does not fit)
It could help when insufficient phosphorylase activation limits flux. Phosphorylase already has nearly complete activating phosphorylation. Additional activation tests a regulatory limitation that the measured phosphate state already opposes.
C. Add functional G6Pase microsomes to the late extract and measure G1P at unchanged glycogen (Why this does not fit)
They could address a deficient terminal glucose-release system. G6P hydrolysis and export capacity are normal. Terminal glucose-release machinery does not replenish the substrate for G1P production.
D. Raise inorganic phosphate in the late extract and measure G1P at unchanged glycogen (Why this does not fit)
It would increase the phosphate substrate for phosphorolysis. The assay already supplies excess phosphate. A phosphate challenge cannot isolate glycogen scarcity when phosphate is already in excess.
Takeaway: A depleted reserve can limit flux through otherwise active machinery.
A. Less glycogen-derived G1P release with greater UDP-glucose incorporation (Why this does not fit)
Greater donor incorporation is compatible with resistance to inhibitory phosphorylation. The phosphorylase activation response matches stimulated wild type. Protecting synthase does not itself suppress the separately measured breakdown signal.
B. Comparable glycogen-derived G1P release with lower UDP-glucose incorporation (Why this does not fit)
A stronger inhibitory effect on synthase could lower incorporation. The variant prevents inhibitory synthase phosphorylation. The altered sites prevent an inhibitory input to synthase.
C. Less glycogen-derived G1P release with comparable UDP-glucose incorporation (Why this does not fit)
Glycogen synthase has the altered phosphorylation sites. The phosphorylase-kinase and phosphorylase response remains intact. This prediction assigns the selective defect to the wrong regulatory arm.
D. Comparable glycogen-derived G1P release with more UDP-glucose incorporation (Best answer)
The measured phosphorylase activation is preserved. cAMP-associated inhibitory phosphorylation cannot restrain the altered synthase sites. The variant retains more incorporation while mobilization remains comparable. Loss of synthesis suppression can coexist with preserved mobilization.
Takeaway: Changing one phosphorylation target can uncouple the opposing pathways.
A. Renal free-glucose release resumes; muscle routes the supplied G6P into local metabolism (Best answer)
Labeled lactate supplied newly synthesized renal glucose. It enters after the blocked precursor conversion. The preserved renal ER system can hydrolyze G6P to free glucose. Muscle still lacks the physiological G6Pase export system. Supplying G6P bypasses the modeled renal precursor block but does not create a muscle export system.
B. Renal free-glucose release remains low; muscle routes the supplied G6P into local metabolism (Why this does not fit)
A terminal ER transport or hydrolysis defect would remain. The experiment preserves both terminal functions. A block before G6P is different from failure of the terminal export system.
C. Renal free-glucose release resumes; muscle also releases comparable free glucose from G6P (Why this does not fit)
Renal cortex has the functioning terminal glucose-release system. Muscle retains glycogen without comparable direct glucose export. The renal rescue does not imply that all glycogen-containing tissues share its terminal machinery.
D. Renal free-glucose release remains low; muscle releases comparable free glucose from G6P (Why this does not fit)
The renal cortical preparation demonstrated that capacity. Skeletal muscle lacks that system. This reverses the relevant tissue capacity and ignores the location of the renal interruption.
Takeaway: Renal cortical gluconeogenesis shares a terminal G6P-to-glucose step without serving as a hepatic-type glycogen reserve.
A. Muscle glycolysis supplies lactate for hepatic gluconeogenesis and glucose export (Best answer)
Lactate carries the initial circulating label. The liver adds labeled glucose to the circulating pool. Hepatic gluconeogenesis converts lactate-derived carbon toward glucose. The supplied timing and hepatic balance support indirect carbon recycling.
B. Muscle pyruvate transamination supplies alanine for hepatic gluconeogenesis and glucose export (Why this does not fit)
Alanine can deliver gluconeogenic carbon to the liver. No labeled alanine is detected in the hepatic inflow. Alanine can support gluconeogenesis, but it is not the demonstrated labeled input here.
C. Previously labeled hepatic glycogen supplies glucose through hepatic glycogenolysis (Why this does not fit)
It would require label already present in hepatic glycogen. Hepatic glycogen is initially unlabeled. An initially unlabeled hepatic reserve cannot explain the new tracer without imported labeled carbon.
D. Renal gluconeogenesis supplies labeled glucose that passes through the hepatic circulation (Why this does not fit)
Renal cortex can produce glucose from gluconeogenic precursors. Labeled glucose is absent from the measured hepatic inflow. Net hepatic production and the inflow measurements distinguish production from passage.
Takeaway: A tracer route requires a carbon carrier and a tissue capable of converting it to the measured product.
A. Synthesis exceeds degradation (Why this does not fit)
It would favor an increase in stored glycogen. The measured added and lost amounts are equal. Positive net storage would require more addition than loss.
B. Degradation exceeds synthesis (Why this does not fit)
It would favor a decrease in stored glycogen. Ten units enter while ten units leave. Net depletion would require more loss than addition.
C. Neither synthesis nor degradation occurs (Why this does not fit)
Glycogen synthesis occurs during the interval. Glycogen degradation also occurs during the interval. The unchanged pool cannot erase the directional tracer measurements.
D. Equal, nonzero synthesis and degradation (Best answer)
Both directions have nonzero flux. The integrated additions and losses balance. Equal integrated fluxes preserve pool size without proving simultaneous rates.
Takeaway: A constant stock does not distinguish inactivity from balanced turnover without flux measurements.
Eight residues enter as G1P. Those residues avoid the hexokinase ATP cost. Not all mobilized residues enter as free glucose.
B. 40 ATP (Why this does not fit)
The payoff reactions form forty ATP. Ten PFK reactions and two hexokinase reactions consume twelve ATP. Forty is the gross payoff before investment reactions.
C. 30 ATP (Why this does not fit)
They enter as free glucose. Hexokinase consumes one ATP for each free-glucose residue. The two hydrolyzed branch residues still pay the hexokinase cost.
D. 28 ATP (Best answer)
Each yields three net ATP on conversion to lactate. Each of the two free-glucose residues yields two net ATP. Eight times three plus two times two equals 28 ATP. Count the two chemical entry routes separately.
Takeaway: Branch-point hydrolysis loses the hexokinase-saving advantage for those residues.
A. Greater vesicular free-glucose release with comparable cytosolic G1P production (Best answer)
It implicates deficient hydrolytic capacity in the acidic fraction. It supplies acidic glycogen hydrolysis to free glucose. Cytosolic G1P production remains comparable under its unchanged assay conditions. Restoring acidic hydrolysis does not require changing cytosolic phosphorolysis.
B. Comparable vesicular free-glucose release with greater cytosolic G1P production (Why this does not fit)
Cytosolic phosphorylase produces G1P. It is delivered exclusively to the vesicular compartment. This would favor a cytosolic intervention rather than the specified vesicular delivery.
C. Comparable vesicular free-glucose release with comparable cytosolic G1P production (Why this does not fit)
Failure of enzyme access to the substrate could prevent a response. Delivery and substrate access are stipulated to be available. No compartmental response would fail to support rescue by functional hydrolase delivery.
D. Greater vesicular free-glucose release with lower cytosolic G1P production (Why this does not fit)
Changing substrate allocation could alter the other route's flux. Cytosolic G1P production is reassayed separately at identical substrate and regulatory conditions. Restoring one route does not establish suppression of the other at fixed assay supply.
Takeaway: A compartment-specific rescue should first be evaluated with a measurement from that compartment.
A. Increased synthesis of additional glycogen-synthase protein (Why this does not fit)
Total synthase protein was unchanged. Blocking new protein synthesis did not prevent the response. The abundance and translation controls oppose an increased enzyme population.
B. Increased allosteric stimulation from a higher assay G6P concentration (Why this does not fit)
G6P can allosterically stimulate synthase. G6P is fixed at the same concentration in the activity comparison. The standardized assay equalizes the proposed allosteric ligand.
C. Altered regulatory phosphorylation of existing synthase (Best answer)
Equal enzyme amounts retain the activity difference, and new protein synthesis is blocked. The assay uses the same G6P concentration in both preparations. Regulatory phosphorylation differs, supporting covalent regulation of existing synthase. The controls support a change in the existing enzyme population.
D. Increased incorporation from greater assay donor or primer availability (Why this does not fit)
It requires UDP-glucose donor and an existing glucan acceptor. UDP-glucose and primer concentrations were matched. The assay holds the necessary donor and acceptor conditions fixed.
Takeaway: A regulated existing enzyme can remain different after substrate conditions are matched.
A. Immediate allosteric inhibition followed by reduced enzyme synthesis (Why this does not fit)
Total phosphorylase protein remains constant. The fall in phosphorylase phosphate supports covalent regulation. The second phase changes enzyme phosphate without changing protein abundance.
B. Immediate allosteric inhibition followed by covalent reinforcement (Best answer)
Glucose can allosterically inhibit hepatic phosphorylase a. Loss of enzyme phosphate demonstrates covalent regulation. It supports the later covalent state as an additional cause of suppression. The two phases support interacting regulatory mechanisms.
C. Immediate covalent inhibition followed by allosteric reinforcement (Why this does not fit)
Phosphorylation was held fixed during that response. The second phase demonstrated loss of phosphorylase phosphate. The first phase excludes a change in protein phosphorylation.
D. Immediate substrate exhaustion followed by covalent reinforcement (Why this does not fit)
Glycogen and inorganic phosphate remain available. Glucose addition tracks the immediate inhibition. Available glycogen and phosphate exclude substrate exhaustion as the first explanation.
Takeaway: Glucose feedback and protein dephosphorylation are distinct regulatory observations.
A. A and B: isolated lysosomal GAA defects (Why this does not fit)
Cytosolic glycogen mobilization and incoming glucose feed glycolysis. Isolated GAA loss does not block that cytosolic reaction. A lysosomal defect does not explain selective failure of neutral cytosolic glycolytic supply.
B. A: defective glycogen mobilization; B: defective PFK (Best answer)
The failure in A lies in the glycogen-specific supply route. Both fuels require PFK to continue glycolysis. Normal uptake and the other specified enzymes leave PFK as the supported site. Glycogen and blood glucose converge before PFK.
C. A: defective PFK; B: defective glycogen phosphorylase (Why this does not fit)
Incoming glucose still passes through PFK. Culture A was rescued, which opposes a PFK block in A. That pairing predicts the opposite glucose rescue.
D. A and B: complete PFK defects (Why this does not fit)
Added glucose restored lactate in A. A complete PFK block would prevent that glycolytic response. Functional glucose-to-lactate metabolism in A requires PFK.
Takeaway: A substrate bypass helps only if it enters beyond the block.
A. A muscle debranching defect with retained limit-dextrin storage (Why this does not fit)
The preparation fails direct incorporation from UDP-glucose despite a primer. It examines synthesis of the glucan reserve rather than clearance of branch limits. Retained degradation intermediates do not explain this direct synthesis failure.
B. A hepatic synthase defect with reduced systemic fasting reserve (Why this does not fit)
Muscle has deficient incorporation. Hepatic glycogen synthesis is preserved. The tissue comparison demonstrates preserved liver synthesis.
C. A muscle synthase defect with reduced local fuel reserve (Best answer)
Muscle glucan elongation remains impaired. The tested downstream glucose-use pathway remains available. The defect reduces local muscle reserve without demonstrating the same hepatic reserve failure. The experiment supports a tissue-specific synthetic localization, not a complete patient diagnosis.
D. A muscle phosphorylase defect with preserved reserve formation (Why this does not fit)
It releases G1P from existing glycogen. It does not perform the synthetic incorporation that fails here. Phosphorylase deficiency impairs use of stored glycogen rather than synthase incorporation from supplied donor.
Takeaway: A local reserve can fail to form even when circulating glucose remains usable.
